Literature DB >> 3091059

Assessment of thrombogenicity of activated and non-activated prothrombin concentrates in a rat model.

S Silberman, J Fareed, J Walenga.   

Abstract

In vitro clotting activity of rats injected with different preparations of prothrombin concentrates was measured. Animals rendered deficient in vitamin K-dependent coagulation factors by early coumadin (warfarin) pretreatment, followed by injections of concentrate preparations were also evaluated. Findings indicate a dose-related response in abnormal coagulation changes demonstrable with each preparation and lack of protection of intravascular coagulation by coumadin anticoagulation. Furthermore, a role for in vivo factor VII activation of haemostasis following concentrate administration could not be elicited.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091059      PMCID: PMC2013040     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  Thromboembolic complications.

Authors:  C K Kasper
Journal:  Thromb Diath Haemorrh       Date:  1975-06-30

2.  Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal.

Authors:  D A Taberner; J M Thomson; L Poller
Journal:  Br Med J       Date:  1976-07-10

3.  Intravascular coagulation with use of human prothrombin complex concentrates.

Authors:  A I Cederbaum; P M Blatt; H R Roberts
Journal:  Ann Intern Med       Date:  1976-06       Impact factor: 25.391

4.  Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion.

Authors:  U Seligsohn; C K Kasper; B Osterud; S I Rapaport
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

5.  Thrombogenic materials in prothrombin complex concentrates.

Authors:  P M Blatt; R L Lundblad; H S Kingdon; G McLean; H R Roberts
Journal:  Ann Intern Med       Date:  1974-12       Impact factor: 25.391

6.  Increased fibrinopeptide A after prothrombin complex concentrates.

Authors:  S Viganó; M Cattaneo; W Gervasoni; P M Mannucci
Journal:  Thromb Haemost       Date:  1980-10-31       Impact factor: 5.249

7.  The factor VIII-independent activation of factor X by factors IXa and VII in plasma.

Authors:  F Ofosu; M A Blajchman; G Modi; J Hirsh
Journal:  Thromb Res       Date:  1981 Jan 1-15       Impact factor: 3.944

Review 8.  Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.

Authors:  J Fareed; H L Messmore; J M Walenga; E W Bermes; R L Bick
Journal:  Semin Thromb Hemost       Date:  1982-10       Impact factor: 4.180

9.  Comparison between two concentrates with factor VIII inhibitor bypassing activity.

Authors:  H Vinazzer
Journal:  Thromb Res       Date:  1982-04-01       Impact factor: 3.944

10.  Thromboembolism following prothrombin complex concentrates and major surgery in severe liver disease.

Authors:  A Marassi; V Manzullo; V di Carlo; P M Mannucci
Journal:  Thromb Haemost       Date:  1978-06-30       Impact factor: 5.249

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.